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The arsenal of effective, standardized treatment options for major
depressive disorder (MDD) is
shockingly low considering one
in three individuals in the United States will experience clinical
depression during their lifetime
(American Psychiatric Association, 2013). MDD is usually limited to drug therapy and cognitive
therapy, and alternative treatment
methods are often disregarded
as ineffective or unethical. This
review explores the possibility of electroconvulsive therapy
(ECT) as an alternative standard
treatment for MDD. ECT has
been used for decades for the
treatment of mood disorders,
but only recently has the medical
community begun to understand
how ECT affects the brain. With
advancements in methodology,
ECT has become a safe, efficient,
and more permanent treatment
option compared to drug therapy.
This research discusses proposed causes of depression in the
pathways of the brain, as well as
specific areas of the brain affected
by drug therapy and ECT. With
recent research demonstrating
the possibility of neurogenesis in
the hippocampus being related to
depressive symptoms, new perspectives on old treatment options
must be explored. This review will
propose the possibility of ECT as
a standard treatment for MDD.
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Despite its controversial history, electroconvulsive therapy
(ECT) is gaining respect as a treatment for intractable cases
of major depressive disorder (MDD). Popular in the 1970s,
ECT was used to treat a variety of disorders until its adverse
effects restricted further use (Friedberg, 1977). Currently ECT
is rarely used as a long-term treatment, but it is used in cases
with high risk of suicide. However, recent studies suggest that
neurogenesis occurs in the brain following electroconvulsive
therapy. This growth of new neural tissue, specifically in the
hippocampus, has been linked to long-term alleviation of
depressive symptoms (Rotheneichner et al., 2014). Therefore,
ECT should again be reviewed as a more standard treatment
option for MDD.
Critical assessment of common current treatments
for MDD reveals significant weaknesses. The most popular
treatment is based on the theory that depression is linked to
increased uptake of serotonin (Mann, 1999; Meyer et al. 2006).
To reduce reuptake and allow serotonin to bind more on the
postsynaptic receptors, selective serotonin reuptake inhibitors
(SSRIs), such as sertraline (also known as Zoloft) or fluoxetine
(also known as Prozac), are prescribed. These medications
have many adverse side effects including heightened suicidal
https://scholarsarchive.byu.edu/intuition/vol12/iss1/3Brigham Young University
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tendencies in low dosage (Ludwig & Marcotte, 2005). In
stark contrast, modern ECT has little visible damage, both
biologically and psychologically (Anderson, Wollman, &
Dinwiddle, 2013). Over the course of thirty years and many
studies, ECT has become sophisticated, controlled, targeted,
and better understood (Hanson, Owens, & Nemeroff, 2011).
Unlike SSRIs which treat systemically, ECT is a localized
treatment that produces minimal systemic side effects
(Eschweiler et al., 2007; Gomez, 1975). Both SSRIs and ECT
appear to promote positive change in brain chemistry and
structure, each modality having its own advantages and
weaknesses (Madsen et al., 2000; Rotheneichner et al., 2014).
Both modalities are based on the monoamine theory of
depression, which dictates that serotonin is key to regulating
mood.
Serotonin is thought to be regulated by the dentate
gyrus, specifically the CA3 region of the hippocampus
(Banasr, Hery, Printemps, & Daszuta, 2004). Recent research
suggests that certain types of stimulation of the brain trigger
the generation of neural precursor cells (NPCs) which are
correlated to neurogenesis within the dentate gyrus and the
CA3 region (Banasr et al., 2004; Hanson et al., 2011; Hellsten et
Published by BYU ScholarsArchive, 2017
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al., 2002). Some stimuli include exercise, hypoxia in controlled
doses, ECT, as well as conventional drug therapy, such as SSRIs
(Kempermann, Kuhn, & Gage, 1997; Zhu et al. 2010; Malberg,
Eisch, Nestler, & Duman, 2000). Due to the pronounced effect
ECT has on the brain in regard to NPCs, many neuroscientists
are now suggesting ECT as a more regular form of therapy for
MDD (Hellsten et al., 2002; Bauer, 2003; Inta & Gass, 2015).
Research has shown that ECT and conventional drug therapy
promote NPC generation in the area of the brain that regulates
serotonin, which suggests stimulating this area of the brain can
treat depression.

Diagnosing and Treating Depression
Over 14 million American adults (6.7% of the U.S. population)
struggle with MDD (Heo, Murphy, Fontaine, Bruce, &
Alexopoulos, 2008). The prevalence of MDD suggests that
almost everyone has either experienced depression or known
someone who has. Physicians use a standardized assessment
to diagnose and then prescribe treatment, generally either
medication, therapy, or both. There are many different
medications, each with different properties and adverse side
effects which range from fatigue or insomnia to increased risk
https://scholarsarchive.byu.edu/intuition/vol12/iss1/3Brigham Young University
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of suicide or erectile dysfunction (Ferguson, 2001). Serotonin
regulation occurs systemically, so side effects from SSRIs
also manifest systemically (Camilleri, 2009). Many people
experience adverse reactions to antidepressants because the
standard starting dose may be excessively strong (Cohen, 2003).
On the other hand, too low of a dose has been shown to lead
to increased risk of suicide (Grunebaum et al., 2004; Ludwig &
Marcotte, 2005). Because of this life-threatening risk, physicians
generally take a cautious approach and prescribe a higher dose
than necessarily needed (Cohen, 2003). Although depression
is a prevalent problem in the US population, current treatment
practices have many negative side effects and are not easy to
prescribe in the proper dosage.

The Diagnosis of Major Depressive Disorder
No physical tests exist for the diagnosis of depression (National
Health Service, 2014). Instead, a general practitioner uses
one of the common rating scales to determine whether or
not treatment should be administered. One such scale is
the Hamilton Rating Scale for Depression (HAM-D), which
outlines the major symptoms of depression (Khan, Khan,
Shankles, & Polissar, 2002; Leucht et al. 2005). These symptoms
Published by BYU ScholarsArchive, 2017
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include sadness, feelings of guilt, suicidal tendencies, insomnia,
difficulty at work, and paranoia (Khan et al., 2002). The
strength of the medication and treatment is determined by the
evaluation and suggestion of the physician or psychologist.
Serotonin within the Hippocampus and its Biological Uses
Treatment for MDD focuses on the physical
manipulation of serotonin. However, levels of serotonin rarely
vary from an individual with depression from an individual
without depression (Marken & Munro, 2000). The monoamine
theory relates to synapses with transporters in the synaptic
cleft and the effectiveness of serotonin within the brain, not
with the actual amount of serotonin (Hirst, Price, Rattray, &
Wilkin, 1998). Serotonin is involved in a number of functions,
including digestion, mood, appetite, sleep, sexual desire and
function, and memory (Buhot, Martin, & Segu, 2000; Labbate,
Grimes, Hiaes, Oleshansky, & Arana, 1998; Portas, Bjorvatn, &
Ursin, 2000; Zhu et al. 2010). This complex system is monitored
within the hippocampus and functionally responds to the
precursor to serotonin, 5-HT (Laplante, Diorio, & Meaney,
2002). The precursor 5-HT is derived from tryptophan,
an amino acid that is obtained solely through diet (Smith,
Fairburn, & Cowen, 1997). This only adds to the complexity
https://scholarsarchive.byu.edu/intuition/vol12/iss1/3Brigham Young University
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regarding diagnosing and understanding mood disorders,
where everything—from diet and exercise to brain chemistry—
could have a major effect.
The hippocampus regulates serotonin, which is
central to the limbic system and associated with memory
processing (Battaglia, Benchenane, Sirota, Pennartz, & Wiener,
2011). This critical area of the brain also acts as a hub for
communications across cortexes in the brain (Battaglia et
al., 2011). Studies suggest that serotonin can affect the shape
of the hippocampus, and that the shape of the hippocampus
can affect its functioning (Voineskos et al., 2015; Smolders,
Loo, Sarre, Ebinger, & Michotte, 2001). This could mean that
the hippocampus’s development, size, or shape may play a
key role in understanding depression. This plasticity allows
for subtle changes in brain chemistry and functioning. These
modifications are often associated with the creation of new
neuronal connections and neurons, known as neurogenesis.
In recent years, research has shown that neurogenesis
is possible in adults (Gabriel et al., 1999; Hellsten et al., 2002;
Malberg et al., 2000). Although studies are still ongoing on how
neurogenesis occurs and how it can be stimulated, there have
been a number of studies proposing that stress can decrease
Published by BYU ScholarsArchive, 2017
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neurogenesis in the hippocampus (Schloesser, Manji, &
Martinowich, 2009). Because the hippocampus is fundamental
to the regulation of serotonin, some scientists speculate that
the effect of stress on the hippocampus is linked to depressive
behavior (Campbell & MacQueen, 2004). This theory opens
the door to new ideas regarding treating depression through
stimulating neurogenesis (Hellsten et al., 2002; Malberg et al.,
2000). In particular, ECT is a promising option.

Neurogenesis within the Hippocampus
The hippocampus is a dynamic part of the brain (Abe, 2001).
Stress, anxiety, depression, and other factors can cause
atrophy in the hippocampus and lead to problems within
the limbic system (McEwen, 1995). To combat this, the body
regulates neural precursor cell growth and decay within the
hippocampus through environmental cues given by neuronal
pathways that pass through the hippocampus (Abe, 2001;
McEwen, 1995). Some specific activities have been identified
that encourage growth in the hippocampus, including aerobic
exercise. One study done by Kempermann, Kuhn, and Gage,
(1997) demonstrated that the dentate gyrus of adult rats
increased in size when exposed to an environment with
https://scholarsarchive.byu.edu/intuition/vol12/iss1/3Brigham Young University
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colors, toys, and other activities to keep the rats engaged.
This example demonstrates that it is not necessary to induce
neurogenesis through artificial means. However, when negative
cues persist, such as chronic stress or depression, damage to
the hippocampus can effectively wipe out the body’s ability
to self-regulate (Campbell & MacQueen, 2004). In these
cases, antidepressants, ECT, and other treatment options for
depression become necessary because it may be difficult to
overcome depression without assistance.
Stress doesn’t only affect the hippocampus. The effects
of stress extend beyond the hippocampus, dampening the
relationship between the hippocampus and the main stress
hormone system, the hypothalamo-pituitary-adrenal (HPA)
axis (Schloesser et al., 2009). Severe chronic stress impairs HPA
axis activity, which mutes the ability of the hippocampus to
modulate downstream brain areas involved in stress response.
In essence, the brain protects itself by destroying pathways that
are overworked, and one of the damaging side effects is MDD
(Schloesser et al., 2009). Of course, this type of manipulation
of the HPA has damaging side effects, most notably MDD,
but is primarily in place to protect the longevity of the brain.
Although all the mechanisms and processes involved are as yet
Published by BYU ScholarsArchive, 2017
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unclear, the importance of neurogenesis in the hippocampus to
regulate stress and serotonin has become widely recognized.

ECT as a Treatment for MDD
Developed in 1938, ECT was found effective for treating a
number of mood disorders, including depression (Endler,
1988). In its early development, however, ECT was done
without precise measurements of voltage or any form of
anesthetic by inducing seizures in patients (Endler, 1988).
Over the course of the next decades as various forms of
treatment began to appear, most notably drug therapy which
had less severe side effects, ECT fell out of favor. Today ECT
has advanced in sophistication, with more precise voltage
calculation and use of anesthesia to literally eliminate the pain
involved (Loo, Schweitzer, & Pratt, 2006). Although it has been
recognized as one of the most effective treatments (Kellner et
al., 2015), its general scope of use is focused on the most severe
cases. Recent studies have begun to demonstrate why ECT is a
valuable form of treatment. The use of ECT has been expanding
over the past decade and continues to grow as research
continues.
Although understanding of the mechanism of ECT
https://scholarsarchive.byu.edu/intuition/vol12/iss1/3Brigham Young University
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has increased, there are still many concerns regarding its
safety; these stigmas continue, even among professional
psychiatrists (Carney & Geddes, 2003). Though death from
ECT was a considerable risk thirty years ago. Refuting this
fear, one study suggests that ECT in the mid-1990s was ten
times safer than childbirth and that approximately six times as
many deaths annually in the U.S. are caused by lightning than
by ECT (Abrams, 1997). The most common side effects are
temporary confusion and memory loss. Uppal, Dourish, and
Macfarlane (2010) suggest that the most dangerous aspect of
ECT treatment is being under anesthetic, and not the actual
treatment. They argue that most concerns regarding ECT are
mostly stigmatic superstition from decades ago.

Current ECT Use
ECT is generally viewed as a last resort for treatment-resistant
depression by the psychiatric community (Al-Harbi, 2012).
Although there are cases when ECT is regularly administered,
its use is far from standard practice. Individuals that receive
ECT usually have experienced adverse effects from medication
or have been unresponsive to therapy (Al-Harbi, 2012). These
individuals range from those who simply need a more rapid
Published by BYU ScholarsArchive, 2017
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response than medications can provide, such as those suffering
from delusions or suicidal tendencies, to those who suffer from
catatonia (Al-Harbi, 2012). Those who receive ECT are highly
likely to continue to receive treatment in the form of drug
therapy (Bauer, 2003). The application of ECT is not limited
to MDD, and is used to treat other mental disorders in similar
circumstances. Regardless, the universal goal is to stabilize the
patient so medications can be started or resumed.
Electroconvulsive therapy is performed with the goal
of “as little as possible,” both in terms of voltage and number
of treatments (Al-Harbi, 2012; Bauer, 2003). Typically,
a single procedure will only last five to 10 minutes, not
including preparation time and recovery. General anesthesia
is administered so that pain is minimized. Patients are given
a muscle relaxant to minimize seizure as well. The electrode
pads are placed on the head either unilaterally or bilaterally,
with location determined to best target the area of interest
(“Electroconvulsive Therapy,” 2015). Electroencephalogram
(EEG) is used to record electrical activity in the brain to make
sure the procedure is done correctly and strongly enough to
induce the desired seizure. Recovery usually lasts for about
one hour before the patient is released. During this time,
https://scholarsarchive.byu.edu/intuition/vol12/iss1/3Brigham Young University
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confusion and memory loss are a common side effect, either
from anesthesia or from the treatment itself (“Electroconvulsive
Therapy,” 2015). In the United States, ECT treatments are
administered in sets of two to three times a week for a month,
for a total of six to twelve treatments, depending on severity of
the case and the physiological reaction to the treatments.
Due to careful localization of the treatment, most
common side effects are temporary and isolated to the parts
of the body affected by the procedure. Confusion, memory
loss, and headache are common, but they generally subside
within 24 hours. Long-term memory loss can take up to a few
months to fully recover, but it is rare for memory loss to persist
beyond that time (MacQueen, Parkin, Marriot, Begin, & Hasey,
2007). As with any medical procedure, especially those that
use anesthesia, there are rare risks of complications, including
cardiac arrest or other heart condition, stroke, and even death
(“Electroconvulsive Therapy,” 2015). Considering the large
success rate among patients suffering from depression and the
minimal risks of ECT warrant ECT to be considered a potential
alternative to conventional drug therapy.
422 ECT treatments: A neuropathological evaluation.
Much of the stigma surrounding ECT is unfounded, as
Published by BYU ScholarsArchive, 2017
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illustrated by the following neuropathological evaluation. In
2013, an autopsy of an 84-year-old man revealed little-to-no
brain damage despite his having received 422 ECT treatments
over 8.6 years (Anderson, Wollman, & Dinwiddle, 2013). This
man had been treated for a severe depressive episode that
culminated in a suicide attempt. After many hospitalizations,
ECT was prescribed, which continued until the time of his
death. The postmortem report was completed immediately
after his death, one month after his final ECT treatment. The
report showed that there was no link between cause of death
and his ECT treatments (Anderson et al., 2013). Although this
is an isolated case, the authors linked a large number of similar
reports from the past twenty years.
ECT has not been shown to cause brain damage
according to this case study and other reports. Stigma regarding
ECT and brain damage stems from postmortem reports dating
to the 1940s, claiming that ECT causes harmful physical
changes to the brain. This stigma remains in part because over
the past four decades, few postmortem studies have been done
due to the low mortality rate after the immediate treatment
period of ECT patients. In the past two decades, computed
tomographic brain imaging has shown no changes in brain
https://scholarsarchive.byu.edu/intuition/vol12/iss1/3Brigham Young University
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structure after ECT (Anderson et al., 2013). Simply put, the
notion that ECT causes brain damage is unfounded.

Discussion
MDD poses a problem for treatment because the precise
mechanisms that cause MDD are unknown. However,
correlations between treatments and behavioral changes spur
innovation. Early ECT was done with minimal understanding
of why it worked, but half a century later, neuroscientists have a
better idea of how the brain is affected by ECT (Endler, 1988).
Early monoamine oxidase inhibitors (MAOIs) were discovered
serendipitously while trying to treat tuberculosis. Subsequent
in vitro work led to a theory of the drug’s mechanism of action
(Ramachandraih, Subramanyam, Bar, Baker, & Yeragani, 2011).
Over the next twenty years, MAOIs were replaced with SSRIs
which have fewer side effects and are more potent. Along
with these advances, ECT became safer and more controlled.
Advanced methods of evaluation, brain scanning technology,
and the ability to perform advanced experiments allow for a
much deeper understanding of treatment options before ever
being released to the general population. As understanding of
the brain increases, methods become more refined.
Published by BYU ScholarsArchive, 2017
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Technological improvement has influenced the
way antidepressants are manufactured and the way ECT is
performed. Studies on rats have demonstrated the effectiveness
of ECT in treating induced depression on a biological level
(Bauer, 2003; Inta & Gass, 2015; Kempermann, Kuhn, and
Gage, 1997). Currently ECT is used as the last resort of
treatment, despite evidence it is safe, effective and has few side
effects. Antidepressants are more prevalent and have more
common side effects that generally are present for as long as the
patient is taking the prescription (Cascade, Kalali, & Kennedy,
2009). Antidepressants are an effective treatment, but as with
any treatment, have their shortcomings and should not be the
only offered solution. This is the precise reason ECT should be
taken into consideration as a viable treatment option.
ECT as a Standard Treatment
The general consensus is that it is safer to take a pill
than undergo ECT, which may be incorrect in the long-term.
A meta-analysis study demonstrated that in severe cases, ECT
is the most effective treatment option (Kellner et al., 2015).
There is less evidence that ECT would be effective in less-severe
cases other than studies on rats with induced depressive states
(Madsen et al., 2000; Theilmann et al., 2014). The lack of studies
https://scholarsarchive.byu.edu/intuition/vol12/iss1/3Brigham Young University
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may be attributed to the limited amount of ECT use in lesssevere cases. In rats, ECT has shown to be effective regardless
of perceived severity of the depression (Madsen et al., 2000;
Theilmann et al., 2014). Although the triggering mechanisms
of antidepressants and ECT are primarily different, the effect
is primarily the same: encouraging neurogenesis in the dentate
gyrus and CA3 region of the hippocampus (Malberg et al.,
2000; Warner-Schmidt et al., 2008).
More detailed studies are required to confirm that ECT
could be standardized as a treatment for MDD. ECT has been
reexamined in a number of studies to advance understanding
of the hippocampus and brain function in rats. If ECT were
considered ethical and effective, another sophisticated tool
would be given to the psychiatric community to better treat and
understand depression and other mood disorders. Of course,
more research is necessary to realize this possibility. In light of
the current research of the effects of ECT on the brain, further
research on ECT should be conducted to confirm its viability to
become a more standard treatment option as an alternative to
drug therapy.
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Appendix A
Tables and Figures
Table 1

Descriptive statistics for critical values
Mean
Std. Deviation
Eating disorders
75.5556
15.59547
Stress
23.3333
6.56481
Sleep quality
12.0794
7.03746

N
63
63
63

Figure 1. Regression line between stress (x axis) and disordered
eating (y axis)
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Figure 2. Regression line between sleep quality (x axis) and dis- ordered eating (y axis)
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